VTE IN KOREA
Venous thromboembolism (VTE) is the third most common cardiovascular disease after myocardial infarction and stroke. 1 More than 600,000 cases of VTE occur annually in the United States of America, and 50,000 deaths due to pulmonary embolism. 2 The annual mortality from VTE surpasses the sum of the mortalities from breast cancer, prostate cancer, AIDS and traffic accidents in Europe. 3 The incidence of VTE in Koreans has been generally found to be lower than Caucasian, but it appears to be rapidly increasing, possibly because of the widespread adoption of a westernized life style 4 and increased awareness of VTE among physicians and the community. Therefore, it is to raise awareness of this health issue to reduce mortality from VTE.
VTE REGISTRY IN KOREA AND ITS CURRENT ACTIVITIES
In order to promote the study on the epidemiology, clinical and basic research of VTE in Koreans, the Korean Society of Hematology (KSH) and Korean Society (p=0.014) ( 4 Patient enrollment began since January 1, 2007, and the registry is the largest registry on VTE in Korea. The aim of the registry is to prospectively collect data on the epidemiology and clinical outcomes of VTE from a large unselected cohort of patients and to provide the data on the true incidence and management of VTE in the real-world.
By the end of the first year, 840 patients with VTE were registered from nine initial university hospitals. A total of 1,121 were registered by the end of 2008, 1,289 by the end of 2009, and 1,463 by April 2010 from 11 hospitals. The first report on the epidemiologic characteristics of 596 consecutive VTE patients was released in October 2007. The proportions of patient over 50 years old was 76% among the 596 VTE patients. VTE developed more frequently in wemen than men. Major risk factors for VTE were old age, cancer, immobilization, surgery, severe medical disease, stroke, and trauma. In 28% (158/596) of the patients, VTE was idiopathic. Cancer was associated with VTE in 24% (134/596) and cancer was detected after diagnosis of VTE in 4% (24/596). Cancer-associated DVT frequently occurred was developed in an atypical location more frequently than DVT without cancer (p=0.0465). PE was more frequently associated with idiopathic VTE than secondary VTE ed studies will be necessary for vitalizing our registry. Because the ultimate goal of VTE study is the improvement in the quality of management, we hope that our registry will be applicable in the development of new drugs and diagnostic reagents or devices. VTE Study, 12 French Multicenter VTE Registry, 13 CHS/ ARIC Study, 14 Danish National Patient Registry, 15 VERI-TY, 16, 17 MASTER, 18 and Registro Informatizado de la Enfermedad Thromboembolica (RIETE), 19, 20 have been used to study different aspects of VTE. The most active and largest registry is the RIETE in which 24,000 VTE patients from 186 hospitals in 13 20, 21 different outcomes in acutely ill medical versus surgical patients with VTE, 21 and management pattern of VTE in the registry. 22 The incidences of fatal PE, fatal bleeding, and major bleeding were significantly higher in acutely ill medical patients compared to surgical patients, suggesting that thromboprophylaxis is necessary in acutely ill medical patients. In 2005, patients with VTE and recent major bleeding prior to VTE diagnosis were studied and found to have poorer clinical outcomes compared with those who had not experienced recent major bleeding. 23 Study of the influence of overweight, 24 and early ambulation in the treatment of VTE demonstrated no influence of extreme overweight and bed rest in patients presenting with acute VTE. 25 In 2006, markers of poor prognosis in acute VTE patients were investigated. Bilateral DVT, renal insufficiency, body weight <70 kg, recent immobility, chronic heart failure, and cancer were associated with an increased risk for adverse events. 26 In VTE patients aged 80 years or older, there is more concern about fatal PE than about bleeding. 27 The relationship between cancer and VTE was extensively studied, [28] [29] [30] [31] [32] [33] and abnormal renal function, metastatic disease, recent major bleeding and recent immobility for 4 days or more have been shown to be associated with an increased risk for both fatal PE and fatal bleeding. VTE in atypical location such as upper extremity, 32, 34 VTE in renal insufficiency, 35 and VTE in pregnancy, postpartum, or with contraceptive use 36, 37 were also investigated.
FUTURE PERSPECTIVES
Maintenance of good quality, secure data and future-orient-
